←

CAH · Cardinal Health, Inc.

Healthcare NYQ United States cardinalhealth.com ↗
Val — — Gro — — Qua — — Mom — — Sta — — Cap— P/S0.22 P/E— Fwd P/E17.41 PEG1.23 52W— – — RSI— Target$273.47 (+11.7%) Beta0.50 Div0.83%
Loading chart…
RSI ()
◈ Pattern Overlays
Loading patterns…
Medical Distribution Dublin, United States 58,788 employees
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low — 52W High
Position in Range —
RSI (14)
0 · Oversold RSI 52 Overbought · 100
Signal Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
3Bullish
7Bearish
0Neutral

Key Signals 2

▼ Double Top Major reversal 2026-09-17 · $227.68
Two peaks ~$253.80 — bearish reversal confirmed
Learn more →
▼ Head & Shoulders Major reversal 2026-09-22 · $224.03
H&S neckline ~$224.03 broken — major bearish reversal
Learn more →

Momentum Signals 8

▲ MACD Bullish Crossover 2026-08-05 · $239.23
▲ MACD Bullish Crossover 2026-09-01 · $239.35
▲ MACD Bullish Crossover 2026-10-02 · $228.3
▼ MACD Bearish Crossover 2026-07-09 · $233.77

View overlays on the price chart via Overview tab → Pattern Overlays.

Next Earnings Nov 05, 2026
Beat Rate 100%
Consensus BUY
Analyst Upside +11.7%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
100% 8/8 quarters
Wall Street Consensus
BUY
14
3
BuyHoldSell
Price Target Range
$273.47 +11.7% upside
Low $235 — High $295
Consensus Current price
Wall Street Analyst Ratings
Sort by
Firm Rating Change Action Date
Profitability
Gross Margin 3.84%Last 12 Months
Operating Margin 1.33%Last 12 Months
Return on Equity N/ALast 12 Months
Revenue Growth 5.80%Year over Year
Free Cash Flow 4.75BLast 12 Months
Free Cash Flow Yield —Last 12 Months
Balance Sheet
Debt / Equity N/AMost Recent Quarter
Current Ratio 0.88Most Recent Quarter
Cash 4.86BMost Recent Quarter
Total Debt 10.00BMost Recent Quarter
Net Debt —Most Recent Quarter
How CAH Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap56.68B
Enterprise Value62.23B
Trailing P/E33.85
Forward P/E17.41
PEG Ratio (5yr)1.23
Price/Sales (ttm)0.22
Price/Book (mrq)-19.78
EV/Revenue0.24
EV/EBITDA14.66
Share Statistics
Avg Vol (3m)1.79M
Shares Outstanding231.56M
Float232.13M
% Held by Insiders0.28%
% Held by Institutions91.43%
Short Ratio4.16
Short % of Float3.32%
Profitability
Gross Margin3.84%
Operating Margin (ttm)1.33%
Profit Margin0.67%
Return on Assets (ttm)3.72%
Return on Equity (ttm)N/A
Income Statement
Revenue (ttm)254.25B
Revenue Growth (yoy)5.80%
Gross Profit (ttm)9.77B
EBITDA4.24B
Net Income (ttm)1.71B
Diluted EPS (ttm)7.23
EPS Growth (yoy)68.80%
Balance Sheet
Total Cash (mrq)4.86B
Total Debt (mrq)10.00B
Debt / Equity (mrq)N/A
Current Ratio (mrq)0.88
Book Value / Share-12.37
Operating CF (ttm)5.17B
Free Cash Flow (ttm)4.75B
Trading & Dividends
Beta (5Y)0.50
50-Day MA237.01
200-Day MA221.76
Fwd Dividend Yield0.84%
Payout Ratio28.33%
Income
Dividend Yield 0.83%Last 12 Months
Annual Rate 2.06Forward
Payout Ratio 28.33%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 28.33%
Monthly Dividends
Ownership Breakdown
Institutional 91.43% Insider 0.28% Public 8.3%
Short Interest 3.32% of float
Moderate
Institutional 13F Holdings

Famous investors who disclosed a position in CAH in their latest SEC 13F filing.

Loading…
Insider Transactions
Open-market buys & sells · one dot per day, sized by $ · follows the filters below
Date Insider Role Transaction Shares Price Value